Interactions of the narcotic l-alpha-acetylmethadol with human cardiac K+ channels.
- Authors
- Kang, Jiesheng; Chen, Xiao Liang; Wang, Hongge; Rampe, David
- Year
- 2003
- Journal
- European journal of pharmacology
- PMID
- 12498903
- DOI
- 10.1016/s0014-2999(02)02700-0
l-alpha-acetylmethadol is a long-acting narcotic analgesic that is used in the treatment of opiate addiction. However, the drug has been associated with cases of QT interval prolongation and ventricular arrhythmia. To understand the mechanism underlying these clinical findings, we examined the effects of l-alpha-acetylmethadol on the cloned human cardiac K(+) channels HERG (human ether-a-go-go-related gene), KvLQT1/minK and Kv4.3. Using patch clamp electrophysiology, we found that l-alpha-acetylmethadol inhibited HERG channel currents in a voltage-dependent manner displaying an IC(50) value of 3 microM. The major active metabolite of l-alpha-acetylmethadol, noracetylmethadol, inhibited HERG with an estimated IC(50) values of 12 microM. l-alpha-acetylmethadol had little or no effect on Kv4.3 or KvLQT1/minK K(+) channel currents at concentration up to 10 microM. We conclude that the proarrhythmic effects of l-alpha-acetylmethadol are due to specific blockade of the HERG cardiac K(+) channel and that its active metabolite noracetylmethadol may provide a safer alternative in the treatment of opiate addiction.
No figures extracted from this document.
No chunks — full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
No citations found.
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| Genome-wide association study of stimulant dependence. | 2021 | 34226506 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Metabolite-centric perspectives on QT prolongation: Molecular mechanisms and clinical implications beyond the parent drug. | Zheng Z et al. | — | 2025 | → |
| Nor-LAAM loaded PLGA microparticles for treating opioid use disorder. | Ingabire D et al. | — | 2024 | → |
| Genome-wide association study of stimulant dependence. | Cox J et al. | — | 2021 | → |
| Progress in agonist therapy for substance use disorders: Lessons learned from methadone and buprenorphine. | Jordan CJ et al. | — | 2019 | → |
| The Impact of Opioids on Cardiac Electrophysiology. | Wedam EF et al. | — | 2016 | → |
| Methadone, QTc interval prolongation and torsade de pointes: Case reports offer the best understanding of this problem. | Vieweg WV et al. | — | 2013 | → |
| Inhibition of HERG potassium channels by celecoxib and its mechanism. | Frolov RV et al. | — | 2011 | → |
| A community-based evaluation of sudden death associated with therapeutic levels of methadone. | Chugh SS et al. | — | 2008 | → |
| [Commentary] Opioids and cardiogram abnormalities: providing treatment based on understanding the risks and benefits. | McCance-Katz EF | — | 2008 | → |
| Methadone-associated long QT syndrome: improving pharmacotherapy for dependence on illegal opioids and lessons learned for pharmacology. | Ehret GB et al. | — | 2007 | → |
| Opioid maintenance: a comparative review of pharmacological strategies. | White JM et al. | — | 2007 | → |
| Blood-brain equilibration kinetics of levo-alpha-acetyl-methadol using a chronically instrumented sheep preparation. | Foster DJ et al. | — | 2006 | → |
| Syncope of a drug addict - a special case. | Chatterjee B et al. | — | 2006 | → |
| Efficacy of dose and contingency management procedures in LAAM-maintained cocaine-dependent patients. | Oliveto A et al. | — | 2005 | → |
| QT interval prolongation in patients on methadone with concomitant drugs. | Piguet V et al. | — | 2004 | → |
| Understanding the structure-activity relationship of the human ether-a-go-go-related gene cardiac K+ channel. A model for bad behavior. | Pearlstein R et al. | — | 2003 | → |